Sector pending / Pharmaceutical PreparationsUpdated 2026-05-10 22:07 UTC

KOSDAQ/314140 stock hub

KOSDAQ/314140 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KOSDAQ/314140is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

53.2B

KOSDAQ

Market data

Live price

Current market quote for this ticker.

Current price

KOSDAQ/314140

In the news

Latest news · KOSDAQ/314140

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E11.3

P25 n/aP50 n/aP75 n/a

ROE4.5

P25 n/aP50 n/aP75 n/a

ROIC4.6

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KOSDAQ/314140 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

198

Groups with data

Currency

KRW

Showing 198 of 198 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	South Korea
Country code	KR
Enterprise value	KRW 58B
Exchange	KOSDAQ
Financial currency	KRW
First seen	2026-05-10
Industry	Pharmaceutical Preparations
Last refreshed	2026-05-10
Market cap	KRW 53.2B
Price	KRW 6,140
Price currency	KRW
Sic	2834
Symbol	kosdaq/314140
Website	https://www.rpbio.co.kr

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	8.8%
EV Earnings	12.39x
EV/EBIT	11.42x
EV/EBITDA	5.05x
EV/FCF	7.98x
EV/Sales	0.43x
FCF yield	13.67%
P/B ratio	0.5x
P/E ratio	11.35x
P/S ratio	0.39x
PE Ratio3 Y	32.51x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	3.73%
EBITDA Margin	8.44%
FCF margin	5.34%
Gross margin	10.14%
Gross Profit	KRW 13.8B
Gross Profit Growth	92.25%
Gross Profit Growth Q	27.76%
Gross Profit Growth3 Y	-8.03%
Gross Profit Growth5 Y	1.07%
Net Income	KRW 4.7B
Net Income Growth Q	-19.33%
Net Income Growth3 Y	2.76%
Net Income Growth5 Y	-4.46%
Pretax Margin	3.4%
Profit Margin	3.44%
ROA	2.01
Roa5y	2.13
ROCE	4.55
ROE	4.47
Roe5y	4.06
ROIC	4.57
Roic5y	4.33

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	11.24%
Cagr3y	-20.87%
EPS Growth Q	-19.39
EPS Growth3 Y	-3.71
EPS Growth5 Y	-12.47
FCF Growth	-5.14%
FCF Growth Q	-57.47%
FCF Growth5 Y	0.83%
OCF Growth	-7.75%
OCF Growth Q	-47.31%
OCF Growth3 Y	121.06%
OCF Growth5 Y	4.04%
Revenue Growth	9.88x
Revenue Growth Q	6.43x
Revenue Growth3 Y	-0.46x
Revenue Growth5 Y	14.84x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.86
Assets	KRW 156.3B
Cash	KRW 14.6B
Current Assets	KRW 57.6B
Current Liabilities	KRW 44.4B
Debt	KRW 19.4B
Debt EBITDA	KRW 1.69
Debt Equity	KRW 0.18
Debt FCF	KRW 2.67
Equity	KRW 107.2B
Interest Coverage	6.13
Liabilities	KRW 49.1B
Long Term Assets	KRW 98.7B
Long Term Liabilities	KRW 4.7B
Net Cash	KRW -4.8B
Net Cash By Market Cap	KRW -9.06
Net Debt EBITDA	KRW 0.42
Net Debt Equity	KRW 0.04
Net Debt FCF	KRW 0.66
Tangible Book Value	KRW 106.4B
Tangible Book Value Per Share	KRW 12,277
WACC	6.11

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.3
Inventory Turnover	5.09
Net Working Capital	KRW 14.9B
Quick ratio	0.75
Working Capital	KRW 13.2B
Working Capital Turnover	KRW 11.79

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.18%
Dividend Growth	0%
Dividend Growth Years	0%
Dividend per share	KRW 50
Dividend Years	1
Dividend Yield	0.81%
Ex Div Date	2025-12-29
Last Dividend	KRW 50

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	11.23%
200-day SMA	6,743
3Y total return	-50.46%
50-day SMA	6,373.8
50-day SMA vs 200-day SMA	50under200
All Time High	20,700
All Time High Change	-70.34%
All Time High Date	2022-09-29
All Time Low	4,560
All Time Low Change	34.65%
All Time Low Date	2024-11-15
ATR	207.3
Beta	0.52
Beta1y	0.42
Beta2y	0.52
Ch YTD	-17.03
High	6,190
High52	9,130
High52 Date	2025-10-14
High52ch	-32.75%
Low	6,000
Low52	5,480
Low52 Date	2025-05-08
Low52ch	12.04%
Ma50ch	-3.67%
Price vs 200-day SMA	-8.94%
RSI	43.1
RSI Monthly	38.15
RSI Weekly	42.21
Sharpe ratio	0.53x
Sortino ratio	1.01
Total Return	0.63%
Tr YTD	-17.03
Tr1w	-3.61%
Tr3m	-8.77%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW 5.1B
Operating Income Growth Q	90.57
Operating Income Growth3 Y	-19.23
Operating Income Growth5 Y	-5.51
Operating margin	3.73

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,306,775%
Net Borrowing	-9,688,603,480
Shares Insiders	61.75%
Shares Out	8,666,361
Shares Qo Q	0.23%
Shares Yo Y	0.18%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW 7.3B
Average Volume	14,462.75x
Bv Per Share	12,364.5
CAPEX	KRW -5.2B
Ch1w	-3.61
Ch1y	11.23
Ch3m	-8.77
Ch3y	-50.76
Ch6m	-17.91
Change	-0.16%
Change From Open	-0.16
Close	6,150
Days Gap	0
Depreciation Amortization	6,411,592,000
Dollar Volume	72,267,800
EBIT	KRW 5.1B
EBITDA	KRW 11.5B
EPS	KRW 541
F Score	7
FCF	KRW 7.3B
FCF EV Yield	12.54x
FCF Per Share	KRW 840
Financing CF	-9,688,603,480
Fiscal Year End	December
Founded	1,983
Graham Number	12268.11492
Graham Upside	99.81
Income Tax	KRW -50.9M
Investing CF	-7,066,099,470
Is Primary Listing	1
Last Report Date	2025-12-31
Lynch Fair Value	KRW 2,705
Lynch Upside	-55.94
Ma150	6,901.9
Ma150ch	-11.04%
Ma20	6,231
Ma20ch	-1.46%
Net CF	-4,285,038,010
Open	6,150
P FCF Ratio	7.31
P OCF Ratio	4.27
Payment Date	2026-04-30
Position In Range	73.68
Ppne	94,335,711,500
Price Date	2026-05-08
Price EBITDA	KRW 4.63
Ptbv Ratio	0.5
Relative Volume	0.81x
Revenue	136,218,902,130x
Tax By Revenue	-0.04x
Tr6m	-17.91%
Volume	11,770
Z Score	2.07

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

KOSDAQ/314140 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.8%

$50.0 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

0 consecutive years of growth

Total shareholder yield

+0.6%

Next ex-dividend date: 2025-12-29

Performance

KOSDAQ/314140 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KOSDAQ/314140?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+61.8%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.2%

Negative means the company is buying back shares.

Technical

KOSDAQ/314140 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

43.1

Neutral momentum band

Price vs 200-day MA

-8.9%

50/200-day relationship not available

Beta (5Y)

0.52

Less volatile than the market

Sharpe ratio

0.53

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KOSDAQ/314140

Hub-level FAQ points readers to the deeper analysis pages.

What is the current kosdaq/314140 stock rating?

kosdaq/314140 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full kosdaq/314140 analysis?

The full report lives at /stocks/kosdaq/314140/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for kosdaq/314140?

The latest report frames kosdaq/314140 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the kosdaq/314140 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.